Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

PDL BioPharma

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

Deal Watch October 2018

$155m. Strongbridge. Biopharma/ Novo. Nordisk. MACRILEN (macimorelin) for diagnosis of adult growth.

Is AstraZeneca looking for its next CEO?

Is AstraZeneca looking for its next CEO? the firm’s commercial head of cardiovascular, metabolism and renal franchise left to head up Novo Nordisk’s biopharma division last month.

Soon-Shiong presents first data on cancer memory vaccine at SITC

Soon-Shiong presents first data on cancer memory vaccine at SITC A novel cancer vaccine developed by biopharma mogul Patrick Soon-Shiong’s NantKwest has shown activity in an early-stage clinical trial.

FCB Health Europe takes aim at strategy development

FCB Health Europe takes aim at strategy development From there, Huzzey moved to UCB Biopharma in Belgium, where she worked initially as European brand lead for CIMZIA, before taking on a role in the UK as head of country

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics